 Graft vs Host Disease
"Graft vs Host Disease" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION.
| Descriptor ID |
D006086
|
| MeSH Number(s) |
C20.452
|
| Concept/Terms |
Graft vs Host Disease- Graft vs Host Disease
- Graft-Versus-Host Disease
- Disease, Graft-Versus-Host
- Diseases, Graft-Versus-Host
- Graft Versus Host Disease
- Graft-Versus-Host Diseases
- Runt Disease
- Disease, Runt
- Graft-vs-Host Disease
- Disease, Graft-vs-Host
- Diseases, Graft-vs-Host
- Graft-vs-Host Diseases
- Homologous Wasting Disease
- Disease, Homologous Wasting
|
Below are MeSH descriptors whose meaning is more general than "Graft vs Host Disease".
Below are MeSH descriptors whose meaning is more specific than "Graft vs Host Disease".
This graph shows the total number of publications written about "Graft vs Host Disease" by people in this website by year, and whether "Graft vs Host Disease" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 | | 1997 | 0 | 1 | 1 | | 1998 | 1 | 4 | 5 | | 2000 | 0 | 2 | 2 | | 2001 | 3 | 0 | 3 | | 2002 | 1 | 2 | 3 | | 2003 | 0 | 1 | 1 | | 2004 | 3 | 1 | 4 | | 2005 | 3 | 4 | 7 | | 2006 | 2 | 3 | 5 | | 2007 | 3 | 5 | 8 | | 2008 | 4 | 3 | 7 | | 2009 | 4 | 5 | 9 | | 2010 | 4 | 2 | 6 | | 2011 | 5 | 3 | 8 | | 2012 | 4 | 5 | 9 | | 2013 | 4 | 0 | 4 | | 2014 | 6 | 2 | 8 | | 2015 | 7 | 4 | 11 | | 2016 | 11 | 5 | 16 | | 2017 | 5 | 2 | 7 | | 2018 | 10 | 7 | 17 | | 2019 | 5 | 4 | 9 | | 2020 | 9 | 0 | 9 | | 2021 | 4 | 1 | 5 | | 2022 | 9 | 0 | 9 | | 2023 | 8 | 1 | 9 | | 2024 | 2 | 3 | 5 | | 2025 | 3 | 1 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Graft vs Host Disease" by people in Profiles.
-
Hammoudi T, Nucera S, Troullioud Lucas AG, Ansari M, Balduzzi A, Bertaina A, Buechner J, Corbacioglu S, Dalle JH, Kalwak K, Lee D, Levine JE, Lindemans CA, Locatelli F, Meisel R, Nierkens S, Ottaviano G, Perez-Martinez A, Pichler H, Prockop SE, Pulsipher MA, Talano JM, Tewari S, Schultz KR, Shah NN, Verneris MR, Boelens JJ. Harmonized immune recovery monitoring after HCT: evidence and practical guidance from the Westhafen Intercontinental Group. Blood Adv. 2025 Dec 09; 9(23):6141-6157.
-
Tufa DM, Hoffmeyer E, Schaller KL, Kooiman B, Woods E, Wang D, Jones D, Hall S, Cruz JC, Verneris MR. Innate lymphoid cells prevent graft-versus-host disease via IL-9-driven T-cell senescence. Blood. 2025 Nov 27; 146(22):2656-2669.
-
Ladas EJ, Collier W, Park H, Auletta JJ, Dvorak CC, August A, Esbenshade AJ, Bhatia M, Fisher BT, Levine JE, Pollock BH, Uhlemann AC, Verneris MR, Walters M, Yu L, Nieder M. A Randomized Clinical Trial Evaluating Lactiplantibacillus Plantarum for the Prevention of GI aGvHD: A Report From the Children's Oncology Group (ACCL1633). Transplant Cell Ther. 2025 Jul; 31(7):452.e1-452.e12.
-
Khandelwal P, Fish JD, Gorfinkel L, Guilcher GMT, Howell J, Nishitani M, Nuechterlein B, Obeng E, Shah AJ, Cuvelier GDE, Rotz S, Williams KM, Duncan CN. Pediatric Transplant and Cellular Therapy Consortium RESILIENT Conference on Pediatric Chronic Graft-versus-Host Disease Survivorship after Hematopoietic Cell Transplantation: Part III. Long-Term Impact of Chronic Graft-versus-Host Disease on Endocrinologic, Cardiovascular, and Metabolic Outcomes in Survivors of Pediatric Hematopoietic Cell Transplantation. Transplant Cell Ther. 2025 May; 31(5):297.e1-297.e15.
-
Eissa H, Cowan MJ, Heimall J. Late effects following hematopoietic cell transplantation for severe combined immunodeficiency: critical factors and therapeutic options. Expert Rev Clin Immunol. 2025 Jan; 21(1):73-82.
-
Kent A, Gil KB, Jones MK, Linden B, Purev E, Haverkos B, Schwartz M, McMahon C, Amaya M, Smith CA, Bosma G, Abbott D, Rabinovitch R, Milgrom SA, Pollyea DA, Gutman JA. Outcomes of Haplo-Cord Versus Dual Cord Transplants: A Single-Center Retrospective Analysis. Transplant Cell Ther. 2025 Apr; 31(4):267.e1-267.e11.
-
Zhang M, Cai J, Gulati V, Khoshpouri P, Orsi M. Acute Graft-versus-Host Disease. Radiographics. 2024 07; 44(7):e230238.
-
Solomon SR, Aubrey MT, Bachier-Rodriguez L, Solh MM, Jackson KC, Zhang X, Roark CL, Holland HK, Morris LE, Bashey A. Revised HLA-DP TCE-Core Permissiveness Model Better Defines Relapse Risk and Survival following Haploidentical Transplant. Transplant Cell Ther. 2024 06; 30(6):608.e1-608.e10.
-
Odabas GP, Aslan K, Suna PA, Kendirli PK, Erdem S, Çakir M, Özcan A, Yilmaz E, Karakukcu M, Donmez-Altuntas H, Yay AH, Deniz K, Altay D, Arslan D, Canatan H, Eken A, Unal E. Alantolactone ameliorates graft versus host disease in mice. Int Immunopharmacol. 2024 Feb 15; 128:111560.
-
Zhang L, Luo L, Chen JY, Singh R, Baldwin WM, Fox DA, Lindner DJ, Martin DF, Caspi RR, Lin F. A CD6-targeted antibody-drug conjugate as a potential therapy for T cell-mediated disorders. JCI Insight. 2023 12 08; 8(23).
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|